|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：S491015 |
| 產(chǎn)品名稱：Sitagliptin Triazecine Analog |
| 產(chǎn)品CAS： |
| 規(guī)格含量：5mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
S491015 |
| 名稱: |
Sitagliptin Triazecine Analog |
| 別名: |
10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione |
| 雜質(zhì): |
Sitagliptin Tablets EP Impurity FP-B |
| 參考CAS號: |
10R: 2088771-61-1 |
| 分子式: |
C??H??F?N?O? |
| 外觀: |
白色至白色固體 |
| 熔點(diǎn): |
>207°C (dec.) |
| 分子量: |
421.3 |
| 儲存: |
-20°C Freezer, Under inert atmosphere |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly, Heated ) |
| 類別: |
Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
